U.S. Markets closed

Weekly Top Insider Buys Highlight for the Week of Feb. 15

- By Shuda Xia

The largest Insider Buys this week were for Celgene Corp. (CELG), Yum Brands Inc. (YUM), Omega Healthcare Investors Inc. (OHI) and Zimmer Biomet Holdings Inc. (ZBH).

Celgene Corp. (CELG): Director Ernest Mario bought 2,000 shares

Director Ernest Mario bought 2,000 shares of CELG stock on Feb. 12 at the average price of $89.99. The price of the stock has increased by 0.78% since.


Celgene Corp. is an American biotechnology company that researches, develops, and commercializes treatments relating to cancer and inflammatory disorders. The company's major product is Revlimid, which in combination with dexamethasone treats multiple myeloma in patients. Revlimid is sold through proprietary risk management distribution programs to ensure safe and appropriate use. The company has a market capitalization of $63.58 billion, and as of Feb. 15 it traded at $90.69.

On Jan. 31 Celgene Corp. reported fourth quarter and full year 2018 results. Net product sales for the quarter was $4.036 billion, a 16% increase year-over-year. Total revenue for the quarter increased 16% year-over-year to $4.037 billion. Net product sales for the full year were $15.265 billion, an 18% increase year-over-year. Net income was $1.073 billion and diluted earnings per share were $1.50 for the quarter.

Yum Brands Inc. (YUM): Director Tanya L. Domier bought 2,652 shares

Director Tanya L. Domier bought 2,652 shares of YUM stock on Feb. 08 at the average price of $94.23. The price of the stock has decreased by 0.12% since.

Yum Brands Inc. is an American international fast food company that is a component of the S&P 500. The company operates numerous well-known brands such as Taco Bell, KFC, Pizza Hut, and WingStreet. The company is the world's largest fast food restaurant in terms of system units, with restaurants in over 135 countries and territories. The company has a market capitalization of $28.8 billion, and as of Feb. 15 it traded at $94.12.

On Jan. 28 Yum Brands Inc. announced that David Gibbs has been promoted to President and Chief Operating Officer, reporting to Chief Executive Officer Greg Creed. Mr. Gibbs has served as the President and CFO of the company for the last two years and has been with the company for a total of 29 years. Mr. Gibbs in his new roles will assume operating leadership of the global KFC Division as well as the U.S. and international businesses of Pizza Hut and Taco Bell.

Omega Healthcare Investors Inc. (OHI): Director Burke W. Whitman bought 1,350 shares

Director Burke W. Whitman bought 1,350 shares of OHI stock on Feb. 14 at the average price of $36.68. The price of the stock has decreased by 0.6% since.

Omega Healthcare Investors Inc. is an American real estate investment firm that primarily invests in healthcare facilities, especially in the sale, construction, and renovation of skilled nursing facilities and assisted living facilities. The company has a market capitalization of $7.38 billion, and as of Feb. 15 it traded at $36.46.

On Feb. 11 Omega Healthcare Investors Inc. reported results for the fourth quarter of 2018 ended Dec. 31, 2018. Net income for the quarter was $64.9 million, or $0.31 per common share, compared to net income of $104.9 million, or $0.51 per common share, during the same quarter prior year. Funds from operations for the quarter was $124.5 million or $0.59 per common share.

Zimmer Biomet Holdings Inc. (ZBH): Director Michael J. Farrell bought 2,000 shares

Director Michael J. Farrell bought 2,000 shares of ZBH stock on Feb. 13 at the average price of $123.62. The price of the stock has increased by 0.02% since.

Zimmer Biomet Holdings Inc. is an American healthcare company that was spun off from Bristol-Myers Squibb in 2001. The company focuses on developing, manufacturing, and marketing orthopedic reconstructive products and is a component of the S&P 500. The company has a market capitalization of $25.22 billion, and as of Feb. 15 it traded at $123.65.

On Feb. 1 Zimmer Biomet Holdings Inc. reported fourth quarter and full year 20115 results. Net sales were $2.071 billion for the fourth quarter, a 0.1% increase compared to net sales during the same quarter prior year. Diluted loss per share was $4.42 for the fourth quarter.

For the complete list of stocks that were bought by their company executives, go to: Insider Trades.

Disclosure: I do not own stock in any of the companies mentioned in the article.

This article first appeared on GuruFocus.